Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Monkeypox Vaccine: Blue Water Biotech Touts Encouraging Preclinical Data From Monkeypox Vaccine Candidate
June 28, 2023
Tickers
BWV
RHHBY
Tags
General
Market News
News
From
Benzinga
Roche's Bispecific Antibody With Fixed-Duration Treatment Scores FDA Approval For Type Of Lymphoma
June 16, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBY
News
Health Care
From
Benzinga
EyePoint's EYP-1901 Tipped to Transform Wet AMD Market, Analyst Predicts Potential $870M Sales by 2035
June 14, 2023
Tickers
EYPT
REGN
RHHBY
Tags
REGN
Benzinga
EYPT
From
Benzinga
New Data Show Roche's Self-Administered Blood Disorder Candidate Achieves Disease Control
June 09, 2023
Tickers
AZN
RHHBF
RHHBY
RHHVF
Tags
Market News
AZN
Health Care
From
Benzinga
AI: An Endless Opportunity or Existential Threat?
June 04, 2023
Tickers
AAPL
GOOGL
ICAD
IRBT
Tags
ICAD
TTD
Stocks to Buy
From
InvestorPlace
Why Shares of Zentalis Pharmaceuticals Dropped This Week
June 02, 2023
Tickers
RHHBY
ZNTL
Tags
Market News
Recent Press Releases
ZNTL
From
Motley Fool
Why Shares of Rain Oncology Are Plummeting Today
May 22, 2023
Tickers
RAIN
RHHBY
Tags
RHHBY
RAIN
Recent Press Releases
From
Motley Fool
Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories
May 17, 2023
Tickers
ABBV
AZN
BCS
CS
Tags
AZN
TGT
RHHBY
From
Benzinga
Roche's Investigational Drug For Relapsing Multiple Sclerosis Reduces Brain Lesions, Data Shows
May 17, 2023
Tickers
MKGAF
RHHBF
RHHBY
RHHVF
Tags
Benzinga
RHHBF
Briefs
From
Benzinga
AI Meets Biotech: Transforming the Drug Development Process
May 16, 2023
Tickers
AZN
BAYRY
RHHBY
SNY
Tags
Market News
AZN
RHHBY
From
InvestorPlace
3 Stocks That Are Reshaping the Future
May 16, 2023
Tickers
MSFT
RHHBY
ZBH
Tags
Stocks to Buy
MSFT
RHHBY
From
InvestorPlace
3 Personalized Medicine Stocks to Buy for Long-Time Returns
May 15, 2023
Tickers
ADPT
EXAS
GSK
ME
Tags
ME
NASDAQ:EXAS,NYSE:GSK,NASDAQ:ADPT,OCTMKTS:RHHBY,NASDAQ:ME
ADPT
From
InvestorPlace
EXCLUSIVE: SAB Biotherapeutics' Influenza Immunotherapy Shows Safety, Efficacy In Early-Stage Trials
May 04, 2023
Tickers
RHHBY
SABS
Tags
Health Care
RHHBY
Exclusives
From
Benzinga
Tempest Therapeutics' TPST-1120 Shines In Early Phase 1b/2 Study: Analysts Get Bullish
April 28, 2023
Tickers
RHHBY
TPST
Tags
Analyst Ratings
General
Price Target
From
Benzinga
Roche's Q1 Highlights: Increased Uptake Of Eye Disease Drug Cushions Sales Decline
April 26, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
News
RHHBY
Market News
From
Benzinga
EXCLUSIVE: SAB Biotherapeutics Releases Topline Data From Discontinued COVID Antibody Trial
April 26, 2023
Tickers
REGN
RHHBY
SABS
Tags
Market News
News
SABS
From
Benzinga
3 Top Biotech Stocks Defying the Bear Market
April 25, 2023
Tickers
BGNE
BIIB
LLY
NVS
Tags
Recent Press Releases
TGTX
VKTX
From
Motley Fool
This Company's Non-Invasive Tech Looks To Be Unique In the Market And Can Help People Take Ownership Over Monitoring Their Health
April 25, 2023
Tickers
ABT
DXCM
RHHBY
TECH
Tags
DXCM
Tech
RHHBY
From
Benzinga
FDA Approves Roche's Polivy Combo Therapy For Untreated Patients With Diffuse Large B-Cell Lymphoma
April 20, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Market News
News
FDA
From
Benzinga
EXCLUSIVE: FDA Grants Expedited Review Status To SAB Biotherapeutics' Influenza Antibody
April 13, 2023
Tickers
RHHBF
RHHBY
RHHVF
SABS
Tags
Health Care
RHHBY
Exclusives
From
Benzinga
Why Shares of Adaptimmune Therapeutics Jumped Tuesday
April 11, 2023
Tickers
ADAP
GSK
RHHBY
Tags
RHHBY
ADAP
Recent Press Releases
From
Motley Fool
Bolt Biotherapeutics Says Phase 1 Data Supports Advancing Into Phase 2 Studies
March 30, 2023
Tickers
BMY
BOLT
RHHBY
Tags
General
BOLT
Market News
From
Benzinga
Roche's Slow Growth Shouldn't Drive Investors Away
March 28, 2023
Tickers
RHHBY
Tags
Market News
Recent Press Releases
RHHBY
From
Motley Fool
Roche Joins Hand With Lilly To Improve Early Diagnosis Of Alzheimer's Disease
March 22, 2023
Tickers
LLY
RHHBY
Tags
News
RHHBY
Market News
From
Benzinga
New Four Year Data For Roche's Evrysdi Reinforces Long-Term Efficacy, Safety Profile In Muscular Atrophy Patients
March 20, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
News
Market News
RHHVF
From
Benzinga
Is Roche a Buy Now?
March 20, 2023
Tickers
RHHBY
Tags
Market News
Recent Press Releases
RHHBY
From
Motley Fool
Sarepta Plunges As FDA Takes Surprise Turn; AdComm Meeting Set For Duchenne Gene Therapy
March 17, 2023
Tickers
RHHBY
SRPT
Tags
Benzinga
General
Biotech
From
Benzinga
FDA Casts Doubts Over Roche's Polivy Label Expansion For Untreated Lymphoma Setting
March 09, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
FDA
News
Market News
From
Benzinga
The Top 7 Growth Stocks in Biotech
March 03, 2023
Tickers
APVO
BEAM
CMRX
DVAX
Tags
NASDAQ:ITOS,NASDAQ:VIR,NASDAQ:BEAM,NASDAQ:KNSA,OTCMKTS:RHHBY,NASDAQ:DVAX,NASDAQ:CMRX,NASDAQ:APVO
APVO
Market News
From
InvestorPlace
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
March 03, 2023
Tickers
EXEL
RHHBF
RHHBY
RHHVF
Tags
General
RHHVF
Market News
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.